Insulin-Like Growth Factor Binding Proteins

"Insulin-Like Growth Factor Binding Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A family of soluble proteins that bind insulin-like growth factors and modulate their biological actions at the cellular level. (Int J Gynaecol Obstet 1992;39(1):3-9)

Descriptor ID	D018969
MeSH Number(s)	D12.776.157.420
Concept/Terms	Insulin-Like Growth Factor Binding Proteins Insulin-Like Growth Factor Binding Proteins Somatomedin-Binding Proteins Somatomedin Binding Proteins IGFBP IGF-Binding Proteins IGF Binding Proteins

Below are MeSH descriptors whose meaning is more general than "Insulin-Like Growth Factor Binding Proteins".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Carrier Proteins [D12.776.157]
Insulin-Like Growth Factor Binding Proteins [D12.776.157.420]

Below are MeSH descriptors whose meaning is related to "Insulin-Like Growth Factor Binding Proteins".

Below are MeSH descriptors whose meaning is more specific than "Insulin-Like Growth Factor Binding Proteins".

Insulin-Like Growth Factor Binding Proteins
Insulin-Like Growth Factor Binding Protein 1
Insulin-Like Growth Factor Binding Protein 2
Insulin-Like Growth Factor Binding Protein 3
Insulin-Like Growth Factor Binding Protein 4
Insulin-Like Growth Factor Binding Protein 5
Insulin-Like Growth Factor Binding Protein 6

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Insulin-Like Growth Factor Binding Proteins" by people in this website by year, and whether "Insulin-Like Growth Factor Binding Proteins" was a major or minor topic of these publications.

Bar chart showing 7 publications over 4 distinct years, with a maximum of 2 publications in 1994 and 2009 and 2019

To see the data from this visualization as text, click here.

Year	Minor Topic	Total
1994	2	2
2009	2	2
2011	1	1
2019	2	2

Below are the most recent publications written about "Insulin-Like Growth Factor Binding Proteins" by people in Profiles.

Guzzi LM, Bergler T, Binnall B, Engelman DT, Forni L, Germain MJ, Gluck E, G?cze I, Joannidis M, Koyner JL, Reddy VS, Rimmel? T, Ronco C, Textoris J, Zarbock A, Kellum JA. Clinical use of [TIMP-2]?[IGFBP7] biomarker testing to assess risk of acute kidney injury in critical care: guidance from an expert panel. Crit Care. 2019 06 20; 23(1):225.

View in: PubMed
Nie Y, Yu S, Li Q, Nirala NK, Amcheslavsky A, Edwards YJK, Shum PW, Jiang Z, Wang W, Zhang B, Gao N, Ip YT. Oncogenic Pathways and Loss of the Rab11 GTPase Synergize To Alter Metabolism in Drosophila. Genetics. 2019 08; 212(4):1227-1239.

View in: PubMed
McLaughlin JM, Olivo-Marston S, Vitolins MZ, Bittoni M, Reeves KW, Degraffinreid CR, Schwartz SJ, Clinton SK, Paskett ED. Effects of tomato- and soy-rich diets on the IGF-I hormonal network: a crossover study of postmenopausal women at high risk for breast cancer. Cancer Prev Res (Phila). 2011 May; 4(5):702-10.

View in: PubMed
Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Role for IGFBP7 in senescence induction by BRAF. Cell. 2010 May 28; 141(5):746-7.

View in: PubMed
Quintos JB, Grover M, Boney CM, Salas M. Autoimmune polyglandular syndrome Type 3 and growth hormone deficiency. Pediatr Diabetes. 2010 Sep; 11(6):438-42.

View in: PubMed
Wajapeyee N, Kapoor V, Mahalingam M, Green MR. Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell lines. Mol Cancer Ther. 2009 Nov; 8(11):3009-14.

View in: PubMed
Emley A, Yang S, Wajapeyee N, Green MR, Mahalingam M. Oncogenic BRAF and the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations. J Cutan Pathol. 2010 Mar; 37(3):344-9.

View in: PubMed
Krause JC, Toye MP, Fisher DJ, Stechenberg BW, Reiter EO, Allen HF. Metabolic abnormalities in human immunodeficiency virus-infected children: two-year follow-up. J Pediatr Endocrinol Metab. 2009 Apr; 22(4):345-51.

View in: PubMed
Brennan AM, Lee JH, Tsiodras S, Chan JL, Doweiko J, Chimienti SN, Wadhwa SG, Karchmer AW, Mantzoros CS. r-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: observational and interventional studies in humans. Eur J Endocrinol. 2009 Feb; 160(2):173-6.

View in: PubMed
Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell. 2008 Feb 08; 132(3):363-74.

View in: PubMed

People

Explore

Similar Concepts

Top Journals